Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant

Anti-spike monoclonal antibodies have proven invaluable in preventing severe outcomes from COVID-19, including hospitalization and death. The rise of the SARS-CoV-2 delta variant begs the question of whether monoclonal antibodies maintain similar efficacy now as they had when the alpha and beta vari...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Horo, John C., Challener, Douglas W., Speicher, Leigh, Bosch, Wendelyn, Seville, Maria Teresa, Bierle, Dennis M., Ganesh, Ravindra, Wilker, Caroline G., Arndt, Richard F., Arndt, Lori L., Tulledge-Scheitel, Sidna M., Hanson, Sara N., Razonable, Raymund R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674496/
https://www.ncbi.nlm.nih.gov/pubmed/35120695
http://dx.doi.org/10.1016/j.mayocp.2021.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674496/
https://www.ncbi.nlm.nih.gov/pubmed/35120695
http://dx.doi.org/10.1016/j.mayocp.2021.12.002

Ejemplares similares